Telix Pharmaceuticals (ASX:TLX) has secured FDA Fast Track for its BiPASS program, opening the pre-biopsy prostate cancer ...

FDA Fast Track designation granted for Telix's BiPASS® program, which is evaluating 68 Ga-PSMA-PET imaging alongside MRI in the pre-biopsy prostate cancer setting. The designation recognizes the ...

PSA is a prostate test, not a cancer test. Any breakdown in the cells of the prostate can make it leak. A raised result could ...

Medvue Concorde medical imaging clinic has become the first in Quebec to acquire the Siemens MAGNETOM Flow.Elite, a next-generation magnetic resonance imaging (MRI) system that integrates artificial ...

A prostate biopsy can tell doctors whether cancer is present, but deciding where to take tissue samples has traditionally been difficult. MRI scans are changing that by helping doctors see suspicious ...

Prostate cancer is the second most common cancer in men worldwide. As clinical guidelines increasingly recommend MRI before ...

Using prostate MRI before a biopsy is a real advance in prostate cancer diagnosis. Multiple randomized trials have shown that ...

Hyperpolarization approaches in magnetic resonance overcome sensitivity limitations imposed by thermal magnetization and are ...

Altamuskin man Shane McCarney is living with stage four metastatic prostate cancer after years supporting cancer patients as a clinical psychologist.

The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients.Telix has positively engaged with the FDA on a New ...

Annalisa (Nalis) Merelli is focused on boys’ and men’s health: She looks into reproductive health, trending treatments, screening approaches, mental health, and everything in between. With more than ...

A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate cancer on MRI scans. Following the practice-changing UCL-led PROMIS and ...